FHTX – foghorn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium
Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at Wall Stre
Foghorn Therapeutics (NASDAQ:FHTX) was upgraded by analysts at BTIG Research to a "strong-buy" rating.
Foghorn Therapeutics (NASDAQ:FHTX) is now covered by analysts at BTIG Research. They set a "buy" rating on the stock.
Form 4 Foghorn Therapeutics For: Jan 13 Filed by: Flagship Pioneering Fund VII General Partner LLC
Form SCHEDULE 13D/A Foghorn Therapeutics Filed by: Flagship Ventures Fund V, L.P.
Form 424B5 Foghorn Therapeutics
Form 8-K Foghorn Therapeutics For: Jan 09
Form 8-K Foghorn Therapeutics For: Dec 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.